CCR2 and aneurysm: Tissue ingrowth is also attenuated by systemic deficiency of both MCP-1 and CCR2 and delivery of systemic MCP-1 neutralizing antibody and CCR2 antagonist, further supporting the mechanistic role of MCP-1 mediated aneurysm healing.